Managing COVID-19 in Low- and Middle-Income Countries

Joost Hopman^{1

2}, Benedetta Allegranzi^{3

4}, Shaheen Mehtar⁵

Affiliations

¹ Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
² Médecins Sans Frontières, Amsterdam, the Netherlands.
³ Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland.
⁴ Institute of Global Health, University of Geneva, Geneva, Switzerland.
⁵ Infection Control Africa Network, Cape Town, South Africa.

Joost Hopman et al. JAMA. 2020.

. 2020 Apr 28;323(16):1549-1550.

doi: 10.1001/jama.2020.4169.

Joost Hopman^{1

2}, Benedetta Allegranzi^{3

4}, Shaheen Mehtar⁵

¹ Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
² Médecins Sans Frontières, Amsterdam, the Netherlands.
³ Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland.
⁴ Institute of Global Health, University of Geneva, Geneva, Switzerland.
⁵ Infection Control Africa Network, Cape Town, South Africa.

No abstract available

MeSH terms